Tenafly, NJ, United States of America

Hariklia Deligianni

USPTO Granted Patents = 170 

 

Average Co-Inventor Count = 4.4

ph-index = 19

Forward Citations = 1,128(Granted Patents)

DiyaCoin DiyaCoin 1.42 


Inventors with similar research interests:


Location History:

  • Edgewater, NJ (US) (1995 - 2007)
  • Tenafly, NY (US) (2007 - 2016)
  • Tenafly, NJ (US) (2003 - 2020)
  • Alpine, NY (US) (2017 - 2021)
  • Yorktown Heights, NY (US) (2007 - 2022)
  • Alpine, NJ (US) (2016 - 2024)

Company Filing History:


Years Active: 1995-2025

where 'Filed Patents' based on already Granted Patents

170 patents (USPTO):

Title: Hariklia Deligianni: Pioneering Innovations in Nanotechnology and Antibacterial Coatings

Introduction:

Hariklia Deligianni, an esteemed inventor and researcher based in Tenafly, NJ (US), has made remarkable contributions to the fields of nanotechnology and antibacterial coatings. With an impressive portfolio of 167 patents, Deligianni continues to revolutionize a range of industries with her cutting-edge inventions. Her latest patents in porous nanostructured electrodes for neurotransmitter detection and prevention of biofilm formation showcase her dedication to advancing technology for improved health and well-being.

Latest Patents:

Deligianni's recent patents highlight her expertise in diverse areas of innovation. One of her notable inventions is the development of porous nanostructured electrodes for the detection of neurotransmitters. This system includes a porous electrode, a pH sensor with a sensing electrode and a reference electrode, and electronic circuitry for reliable and accurate measurements. By providing a sensitive and efficient method for detecting neurotransmitters, this technology has the potential to revolutionize the diagnosis and treatment of neurological disorders.

Another significant invention by Deligianni involves the prevention of biofilm formation. Her antibacterial coatings utilize a combination of branched polyethylenimine (BPEI) and glyoxal layers. These coatings can be modified with various characteristics such as superhydrophobic, superhydrophilic, or negatively charged moieties to enhance their antifouling properties. Additionally, the coatings can be modified with bactericidal moieties to effectively combat the growth of harmful bacteria. With this innovation, Deligianni addresses a critical issue in healthcare settings and other industries where biofilm formation poses a significant challenge.

Career Highlights:

Throughout her illustrious career, Deligianni has held notable positions in renowned companies such as IBM (International Business Machines Corporation) and Ebara Corporation. Working with these industry leaders, she has harnessed her innovative mindset and technical expertise to bring forth groundbreaking inventions. Deligianni's contributions have significantly advanced the fields of electronics, nanomaterials, and biomedical engineering.

Collaborations:

Deligianni has collaborated with exceptional professionals in her field, including Naigang Wang and Eugene John O'Sullivan. These collaborations have enhanced the synergy of ideas and expertise, leading to the development of novel solutions to complex scientific challenges. Deligianni's ability to foster collaborations demonstrates her commitment to achieving meaningful advancements through a multidisciplinary approach.

Conclusion:

Hariklia Deligianni's exceptional talent for innovation and dedication to pushing the boundaries of scientific exploration have propelled her to the forefront of technological advancements. With her extensive patent portfolio and significant contributions to nanotechnology and antibacterial coatings, Deligianni continues to make a lasting impact on various industries. Her groundbreaking inventions pave the way for safer and more efficient technologies, bringing us closer to a future enriched by innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…